Charles River Laboratories International (CRL) Cash from Investing Activities Growth (1y) (2010 - 2025)
Charles River Laboratories International (CRL) Cash from Investing Activities Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 156.94% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -3,832.95% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 24.18% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 32.46% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -10.12% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -91.12% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -148.98% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 95.92% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -8.06% |
| 10 | Charles River Laboratories International | 12.89 Bn | 12.68 Bn | 1.81 Bn | -21.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -21.95% |
| Sep 27, 2025 | -58.02% |
| Jun 28, 2025 | 39.65% |
| Mar 29, 2025 | 46.99% |
| Dec 28, 2024 | 68.07% |
| Sep 28, 2024 | 73.20% |
| Jun 29, 2024 | 19.24% |
| Mar 30, 2024 | 49.12% |
| Dec 30, 2023 | -637.08% |
| Sep 30, 2023 | 13.70% |
| Jul 1, 2023 | 83.42% |
| Apr 1, 2023 | -72.05% |
| Dec 31, 2022 | 376.88% |
| Sep 24, 2022 | 74.04% |
| Jun 25, 2022 | 51.57% |
| Mar 26, 2022 | 28.98% |
| Dec 25, 2021 | 110.53% |
| Sep 25, 2021 | -401.41% |
| Jun 26, 2021 | -3,233.31% |
| Mar 27, 2021 | 66.64% |